Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

SGI-1776

SKU: orb1304563

Description

SGI-1776 is a Pim kinase inhibitor investigated in preclinical and clinical research for hematological and solid tumors. Studies have explored its application in prostate cancer, non-Hodgkin's lymphoma, and relapsed/refractory leukemias, demonstrating activity in both in vitro and in vivo models.

Research Area

Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Signal Transduction

Images & Validation

Key Properties

CAS Number1025065-69-3
MW405.42
Purity>99.99% (May vary between batches)
FormulaC20H22F3N5O
SMILESCN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1
TargetApoptosis,Autophagy,FLT,Pim
SolubilityEthanol:75 mg/mL (184.99 mM);10% DMSO+40% PEG300+5% Tween-80+45% Saline:2.5 mg/mL (6.17 mM);DMSO:52 mg/mL (128.26 mM)

Bioactivity

Target IC50
Pim3:69 nM|Pim2:363 nM|FLT3:44 nM|Pim1:7 nM
In Vivo
SGI-1776 induces dose-dependent apoptosis in CLL cells through a mechanism that involves a decrease in Mcl-1. Additionally, in vitro, SGI-1776 demonstrates cytotoxicity with an average relative IC50 value of 3.1 mM. Beyond targeting Pim, SGI-1776 effectively targets FLT3 with an IC50 of 44 nM. It also induces apoptosis in AML cells in a concentration-dependent manner and shows cytotoxic effects on primary AML cells, leading to a reduction in Mcl-1 protein.
In Vitro
SGI-1776 has demonstrated preclinical activity against leukemia and solid tumor cell line models, with IC50 values ranging from 0.005 to 11.68 mM. It induced a significant difference in the distribution of in vivo EFS (event-free survival) in 9 out of 31 solid tumor xenografts and in 1 out of 8 evaluable ALL (acute lymphoblastic leukemia) xenografts. Furthermore, SGI-1776 has proven effective in mouse models harboring the MV-4-11 tumor.
Cell Research
Cells are cultured in IMDM (ATCC) supplemented with 10% FBS and grown in a 37oC incubator with 5% CO2. Cells are routinely tested for Mycoplasma infection using a commercially available kit. Cells are treated with DMSO or various concentrations of SGI-1776 for 24 hours. Cells (1×106) are washed, then resuspended in 100 μL of annexin binding buffer, mixed with 5 μL of FITC solution and 5 μL of propidium iodide (PI; 50 μg/mL) solution. For each sample, 1×104 cells are measured using a Becton Dickinson FACSCalibur flow cytometer. (Only for Reference)

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Pim, Pim1, Pim3, Pim2, Pim-Kinase Inhibitor IX, SGI 1776, SGI1776, SGI-1776, SGI-1776 free base, Autophagy, Apoptosis, FLT3

Similar Products

  • SGI-1776-VHL-02 [orb3218228]

    3013618-84-0

    974.14

    C50H62F3N9O6S

    50 mg, 5 mg, 10 mg, 1 ml x 10 mM (in DMSO), 100 mg, 1 mg, 25 mg
  • TP-3654 [orb1226449]

    >98% (HPLC)

    1361951-15-6

    418.4553096

    C22H25F3N4O

    5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 500 mg, 1 g
  • SGI-1776 [orb1227131]

    >98% (HPLC)

    1025065-69-3

    405.42

    C20H22F3N5O

    2 mg, 5 mg, 10 mg, 25 mg, 100 mg, 200 mg, 500 mg, 50 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 80.00
5 mg
$ 140.00
1 ml x 10 mM (in DMSO)
$ 140.00
10 mg
$ 220.00
25 mg
$ 360.00
50 mg
$ 500.00
100 mg
$ 630.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry